Trump denies reports of a $300B Iran Reconstruction & Development Fund, says U.S. won’t invest; deal includes reopening ...

Rocket Lab lost roughly $25 billion in market value despite maintaining strong operational momentum and growth outlook.

Healthcare stocks have remained in focus as investors look for companies that can deliver strong operational growth while ...

CarMax rallied in early trading on Wednesday after cruising past consensus estimates with its first-quarter earnings report.

AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...

Netflix (NFLX) has no interest in acquiring Lionsgate Studios (LION), contradicting prior reports and causing LION shares to ...

BrightView Holdings analysis: operational gains vs. weak EPS outlook. Click here to read more on the BV stock.

Power Solutions International faces a deteriorating near-term outlook, with Q1 FY26 revenue down 5.1% and significant margin ...

Royal Caribbean Cruises's stock price uptick in the past two months has exceeded my expectations even for the full year 2026, ...

Unusual Machines targets U.S. reshoring for drone parts; Q1 2026 revenue surged 296% YoY but losses persist. Click here to ...

Powell Industries poised for AI/electrification boom: record orders + $1.8B backlog, self-funded expansion, FY26 tailwinds.

Veraxa Biotech (VRXA) rated Sell: shares look overvalued post‑SPAC. The pipeline’s fragility is pronounced. See here for more ...